Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |